• 
• http://www.nature.com/onc
• Editor: Dr John Jenkins, Dr E Premkumar Reddy
• Volume 27: 58 issues** per year
• ISSN: 0950-9232
• EISSN: 1476-5594
• Impact factor : 6.44*
• Impact ranking: 14/132 in Oncology; 14/132 in Genetics & Heredity; 26/156 in Cell Biology; 32/263 in Biochemistry & Molecular Biology*
• Date Established: 1987
• Published on behalf of:

Aims and Scope:

Oncogene covers all aspects of the structure and function of oncogenes, in particular: cellular oncogenes and their mechanism of activation, structure and function of their encoded proteins, oncogenes of the DNA and the RNA tumor viruses, the molecular oncology of human tumors, tumor suppressor genes; growth regulatory genes, cell cycle control, growth factors and receptors, apoptosis, immortalization and cellular senescence.

Oncogene Reviews
These issues are specially commissioned by the editors and include reviews on topics of particular current interest.

**50 issues of Oncogene plus 8 Oncogene Reviews.

Readership:

All researchers interested in the molecular biology of malignant change including molecular biologists, cell biologists, oncologists, geneticists and biotechnologists.

Oncogene provides:

• Original Articles - high-quality, peer-reviewed, articles covering the latest developments in cancer research and the structure and function of oncogenes.
• Reviews - commissioned from leaders in the field, Reviews vary in length depending on the topic addressed. All reviews are supplemented with glossary explanations and highlighted references that are accompanied by an explanation as to why these references are essential reading.
• Letters to the Editor -correspondence between readers, authors, and the community. Letters to the editor deal with subjects that have recently been addressed in the journal or can introduce new topics.
• Meeting Reports - provides background information on recent meetings relevant to leukemia and related areas. These manuscripts describe information presented by the speakers and summarize their key points.
• Commentaries - a popular forum for provocative debate which gives experts a means by which to discuss, consider, and argue their cases.
• Research Highlights - these short articles highlight exciting primary articles published in Oncogene on a monthly basis.

What makes Oncogene stand apart from the rest of the competition?

• Oncogene Reviews - an in-depth look into the molecular biology of malignant change... Every year, Oncogene publishes a series of review issues which take a closer look into the most current research and advances that are impacting the study of cancer.
• FREE archive accessibility - Free to all readers, the complete text of all articles in the back archive four years after publication; tables of contents and abstracts for all articles published since 1997 and the complete text of the January issue of corresponding year.
• Online features at your fingertips - Easy access to the research you need at any time, including:
  • Electronic manuscript submission via eJournal Press
  • Full-text HTML articles with links to MEDLINE and CrossRef
  • PDF versions of all articles for easy printing
  • Free access to research abstracts
  • Free selected articles each week
  • Free Table of Contents e-alerts service

Online features and site license access:

• Online archive available back to January 1997.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period. Archive content is freely available after five years.
• Users have access to all the online features of nature.com. Find out more >>
• Site license customers will benefit from the services available. Find out more >>
• Indexed in Medline (PubMed), Elsevier BIOBASE/Current Awareness in Biological Sciences, Current Contents, Current Contents Life Sciences, EMBASE, Research Alert, Science Citation Index, BIOSIS, SciSearch, Biotechnology Citation Index and Index Veterinarians.

*2007 Journal Citation Report (Thomson Reuters, 2008)